نتائج البحث 331-340 من 23112 لعملية البحث عن Treatment
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
Patient-Centered Outcomes In The Surgical Treatment Of Uterovaginal Prolapse. Jacksonville, Fla., Rochester, Minn. The purpose of this study is to compare two ...
Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these ...
The purpose of this study is to determine how well the addition of olaparib to the usual treatment, temozolomide, works in treating patients with neuroendocrine ...
Tafasitamab, Lenalidomide And Venetoclax For The Treatment Of Relapsed Or Refractory Mantle Cell Lymphoma. Rochester, Minn. The purpose of this study is to ...
The goal of this clinical research study is to learn how often breast cancer recurs (returns after treatment) in the breast in patients who have been treated ...
The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and ...
The purpose of this study is to gain a better understanding of the presentation, diagnostics, disease course and treatment variations, as well as the ...
... treatment of future patients. Circulating Tumor Nucleic Acids To Monitor Treatment Response In Metastatic Melanoma Patients. Scottsdale/Phoenix, Ariz. This ...
... treatment of pancreatic neuroendocrine tumors that have spread to ... Giving atezolizumab with usual treatment may work better than usual treatment alone.
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.